Skip to main content
. 2015 Jan 9;10(1):e0116769. doi: 10.1371/journal.pone.0116769

Figure 3. Forest plot depicting the odds ratios of mortality of patients receiving extended or continuous versus conventional intermittent infusion of piperacillin/tazobactam.

Figure 3